FDA Inspection 1166893 — Vanderbilt University Medical Center
The FDA completed an inspection of Vanderbilt University Medical Center on Mar 31, 2022 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 31, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Nashville, TN (United States)